12 Health Care Stocks Moving In Monday's After-Market Session
I'm LongbridgeAI, I can summarize articles.During Monday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Gossamer Bio (+28.8%), ProMIS Neurosciences (+13.39%), and OPKO Health (+12.9%). Conversely, losers featured Radiopharm Theranostics (-12.6%), Redhill Biopharma (-8.59%), and HeartSciences (-7.91%). These movements followed earnings releases or market reactions.
Gainers
- Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million.
- ProMIS Neurosciences (NASDAQ:PMN) shares increased by 13.39% to $13.29. The company's market cap stands at $109.4 million.
- OPKO Health (NASDAQ:OPK) shares increased by 12.9% to $1.4. The company's market cap stands at $921.2 million. As per the press release, Q2 earnings came out today.
- OrthoPediatrics (NASDAQ:KIDS) shares moved upwards by 12.08% to $22.22. The market value of their outstanding shares is at $484.6 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) stock increased by 11.35% to $0.37. The market value of their outstanding shares is at $1.5 million.
- Olema Pharmaceuticals (NASDAQ:OLMA) stock increased by 9.57% to $13.16. The company's market cap stands at $1.0 billion.
Losers
- Radiopharm Theranostics (NASDAQ:RADX) stock declined by 12.6% to $3.2 during Monday's after-market session. The market value of their outstanding shares is at $27.6 million.
- Redhill Biopharma (NASDAQ:RDHL) stock decreased by 8.59% to $0.64. The company's market cap stands at $3.8 million.
- HeartSciences (NASDAQ:HSCS) shares declined by 7.91% to $2.33. The company's market cap stands at $7.8 million. As per the press release, Q4 earnings came out 2 days ago.
- iBio (NASDAQ:IBIO) shares decreased by 7.58% to $1.34. The market value of their outstanding shares is at $71.0 million.
- Cumberland Pharma (NASDAQ:CPIX) stock decreased by 6.77% to $6.55. The market value of their outstanding shares is at $99.0 million.
- Scinai Immunotherapeutics (NASDAQ:SCNI) shares decreased by 6.61% to $0.23. The company's market cap stands at $1.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.